Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01240395
Other study ID # MBCT-MCS
Secondary ID
Status Completed
Phase N/A
First received November 10, 2010
Last updated February 17, 2014
Start date September 2011
Est. completion date May 2013

Study information

Verified date February 2014
Source The Danish Research Centre for Chemical Sensitivities
Contact n/a
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research Ethics
Study type Interventional

Clinical Trial Summary

The objective of this study is to evaluate the effect of mindfulness-based cognitive therapy (MBCT) on physical symptoms attributed to chemical exposures, psychological distress, illness worry, quality of life, and illness perceptions in patients suffering from multiple chemical sensitivity (MCS). Furthermore, a secondary objective is to evaluate whether a possible symptom reduction is mediated by an increased level of mindfulness.

The primary hypothesis is that the self-reported severity of MCS symptoms and the degree to which chemical exposures causes symptoms and the impact on daily life will be significantly improved in the MBCT treatment group as compared to the control group.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Fulfil Lacour's criteria for Multiple Chemical Sensitivity

- Sign a written informed consent form

Exclusion Criteria:

- A psychotic or bipolar disorder

- An acute psychiatric disorder requiring other treatment

- Suicidal ideations

- Current alcohol or drug abuse

- Previously engaged in a mindfulness programme

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-based Cognitive Therapy (MBCT)
MBCT is partly based on the mindfulness-based stress reduction program (MBSR), developed by Jon Kabat-Zinn and colleagues, and partly on cognitive therapy for depression, the latter influence particularly expressed through the aspect of "decentering", meaning not accepting the content of thoughts as facts and not identifying with the thought. The MBCT programme in this study includes 2½ hours of training once a week for 9 weeks. In addition, participants are encouraged to practice at home for up to 45 min per day, 6 days a week during the entire course.

Locations

Country Name City State
Denmark The Danish Research Centre for Chemical Sensitivities Ledreborg Allé 40, 2. Gentofte

Sponsors (1)

Lead Sponsor Collaborator
The Danish Research Centre for Chemical Sensitivities

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Quick Environmental Exposure and Sensitivity Inventory (QEESI) QEESI is a screening instrument for MCS. 8 weeks, 1 year follow up No
Secondary The brief illness perception questionnaire (Brief IPQ) 8 weeks, 1 year follow up No
Secondary The Five Facet Mindfulness Questionnaire (FFMQ) 8 weeks, 1 year follow up No
Secondary Symptom Check List 92 (SCL-92) 8 weeks, 1 year follow up No
Secondary The Perceived Stress Scale (PSS-10) 8 weeks, 1 year follow up No
Secondary The World Health Organization Quality of Life (WHOQOL-BREF) 8 weeks, 1 year follow-up No
Secondary Rumination-reflection questionnaire (RRQ) 8 weeks, 1 year follow-up No
Secondary Self compassion scale short form 8 weeks, 1 year follow up No
Secondary The role work functioning index 8 weeks, 1 year follow-up No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04935307 - Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder or MCS Compared to Healthy Controls N/A
Completed NCT00810329 - Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome N/A
Completed NCT01834781 - Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity N/A